Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.59%75.45B | 5.44%314.53B | 2.46%72.83B | 7.68%298.3B | 10.81%88.07B | 4.44%70.61B | 3.52%68.53B | 11.55%71.08B | 6.06%277.02B | 1.37%79.48B |
| Cost of revenue | 4.79%51.23B | 5.28%209B | 2.66%48.89B | 5.59%198.52B | 9.67%56.56B | 3.48%48.44B | -0.25%45.91B | 9.20%47.62B | 5.87%188.01B | -2.29%51.57B |
| Gross profit | 1.15%24.22B | 5.77%105.53B | 2.06%23.94B | 12.10%99.77B | 12.91%31.52B | 6.60%22.17B | 12.13%22.63B | 16.63%23.46B | 6.48%89.01B | 8.92%27.92B |
| Operating expense | 8.91%21.09B | 7.74%81.59B | 9.98%19.37B | 5.73%75.73B | 11.34%20.67B | 4.88%19.07B | 3.08%18.38B | 3.30%17.61B | 5.94%71.63B | -2.49%18.57B |
| Staff costs | 9.97%8.49B | 2.95%31.97B | 10.91%7.72B | 5.98%31.05B | 9.11%9.25B | 4.80%7.42B | 6.15%7.43B | 3.10%6.96B | 5.34%29.3B | -0.32%8.47B |
| Selling and administrative expenses | -3.11%2.59B | 6.54%13.75B | 12.23%2.67B | 6.50%12.9B | 15.72%5.64B | 1.72%2.48B | -2.35%2.41B | 1.62%2.38B | -2.47%12.12B | -5.69%4.87B |
| -Selling and marketing expense | ---- | 6.83%2.52B | ---- | 17.73%2.36B | ---- | ---- | ---- | ---- | -3.61%2B | ---- |
| -General and administrative expense | -3.11%2.59B | 6.48%11.23B | 12.23%2.67B | 4.28%10.55B | 14.32%3.28B | 1.72%2.48B | -2.35%2.41B | 1.62%2.38B | -2.24%10.11B | -7.09%2.87B |
| Depreciation and amortization | ---- | -1.36%2.32B | ---- | -0.84%2.35B | ---- | ---- | ---- | ---- | 8.47%2.37B | ---- |
| -Depreciation | ---- | -1.36%2.32B | ---- | -0.84%2.35B | ---- | ---- | ---- | ---- | 8.47%2.37B | ---- |
| Rent and land expenses | 18.08%2.52B | -2.43%8.67B | -6.08%2.13B | -1.84%8.89B | 5.60%2.45B | -5.14%2.09B | -5.87%2.08B | -2.33%2.27B | 15.16%9.06B | 0.39%2.32B |
| Other operating expenses | 9.56%7.5B | 21.16%24.89B | 14.08%6.85B | 9.32%20.54B | 85.90%989M | 9.57%7.08B | 4.98%6.47B | 6.55%6B | 8.43%18.79B | -39.48%532M |
| Operating profit | -31.69%3.13B | -0.42%23.94B | -21.78%4.58B | 38.34%24.04B | 16.02%10.85B | 18.50%3.1B | 80.95%4.25B | 90.71%5.85B | 8.77%17.38B | 41.89%9.35B |
| Net non-operating interest income (expenses) | -265.63%-117M | -176.62%-213M | -14.29%-32M | 47.97%-77M | 95.65%-2M | 35.14%-24M | 30.30%-23M | 12.50%-28M | -14.73%-148M | -31.43%-46M |
| Non-operating interest income | 100.00%26M | 18.42%90M | 85.71%13M | 137.50%76M | 300.00%44M | 100.00%12M | 30.00%13M | 40.00%7M | 45.45%32M | 120.00%11M |
| Non-operating interest expense | 217.78%143M | 98.04%303M | 28.57%45M | -15.00%153M | -19.30%46M | -16.28%36M | -16.28%36M | -5.41%35M | 19.21%180M | 42.50%57M |
| Net investment income | -7.78%498M | -11.58%985M | 16.88%540M | -9.65%1.11B | 157.50%206M | 68.12%385M | -74.90%61M | -32.16%462M | -0.56%1.23B | -71.01%80M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -65.26%1.4B | 19.88%4.04B | 100.50%4.02B | -22.50%3.37B | -1,035.29%-386M | -96.57%77M | -22.52%1.67B | 8,808.70%2B | 11.42%4.34B | -101.09%-34M |
| Income from associates and other participating interests | -30.92%362M | 174.31%1.4B | 113.88%524M | 8.74%510M | 345.45%147M | 44.90%142M | -138.10%-24M | -10.91%245M | 18.73%469M | -53.52%33M |
| Special income (charges) | -466.67%-17M | 9.22%-187M | 90.32%-3M | 58.80%-206M | 26.87%-98M | 72.54%-53M | 11.11%-24M | 78.77%-31M | -500M | -152.55%-134M |
| Less:Other special charges | 333.33%13M | 1.17%173M | -78.57%3M | -52.10%171M | 319.05%88M | -71.34%47M | -15.38%22M | -90.41%14M | 569.74%357M | 106.58%21M |
| Less:Write off | --4M | -60.00%14M | --0 | -75.52%35M | -91.15%10M | -79.31%6M | 100.00%2M | --17M | 88.16%143M | 76.56%113M |
| Other non-operating income (expenses) | -29.17%85M | -35.50%525M | -47.14%120M | 114.78%814M | 70.67%128M | 13.60%142M | 193.52%317M | 219.72%227M | 28.47%379M | -11.76%75M |
| Income before tax | -45.28%5.33B | 3.12%30.48B | 11.60%9.74B | 27.69%29.56B | 16.32%10.84B | -25.83%3.77B | 28.10%6.22B | 124.26%8.73B | 6.82%23.15B | -10.12%9.32B |
| Income tax | -72.80%822M | -5.95%8.4B | 13.61%3.02B | 28.75%8.93B | 23.36%3.01B | -25.66%1.24B | 34.22%2.02B | 101.36%2.66B | 5.17%6.94B | -19.76%2.44B |
| Net income | -32.90%4.51B | 7.04%22.08B | 10.72%6.72B | 27.23%20.63B | 13.81%7.83B | -25.90%2.52B | 25.35%4.21B | 136.08%6.07B | 7.55%16.21B | -6.09%6.88B |
| Net income continuous operations | -32.89%4.51B | 7.04%22.08B | 10.72%6.72B | 27.23%20.63B | 13.82%7.83B | -25.92%2.52B | 25.36%4.21B | 136.03%6.07B | 7.54%16.21B | -6.11%6.88B |
| Noncontrolling interests | 108.33%9M | -89.66%36M | -5,500.00%-108M | 13.36%348M | 16.98%186M | 7.69%70M | 15.38%90M | -60.00%2M | 274.39%307M | 37.07%159M |
| Net income attributable to the company | -34.09%4.5B | 8.70%22.05B | 12.55%6.82B | 27.50%20.28B | 13.75%7.65B | -26.60%2.45B | 25.62%4.12B | 136.52%6.06B | 6.10%15.91B | -6.77%6.72B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -34.09%4.5B | 8.70%22.05B | 12.55%6.82B | 27.50%20.28B | 13.75%7.65B | -26.60%2.45B | 25.62%4.12B | 136.52%6.06B | 6.10%15.91B | -6.77%6.72B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -34.09%47.52 | 8.71%232.93 | 12.55%72.1 | 31.33%214.27 | 16.78%80.78 | -24.21%25.92 | 29.69%43.51 | 144.22%64.06 | 7.86%163.15 | -5.08%69.17 |
| Diluted earnings per share | -34.09%47.52 | 8.71%232.93 | 12.55%72.1 | 31.33%214.27 | 16.78%80.78 | -24.20%25.9177 | 29.69%43.51 | 144.22%64.06 | 7.86%163.15 | -5.08%69.17 |
| Dividend per share | 0 | 9.30%94 | 0 | 56.36%86 | 30.30%43 | 0 | 95.45%43 | 0 | 37.50%55 | 65.00%33 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |